HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 246 filers reported holding HAEMONETICS CORP in Q3 2021. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $67,000 | +13.6% | 912 | 0.0% | 0.02% | +18.8% |
| Q2 2022 | $59,000 | +3.5% | 912 | 0.0% | 0.02% | +23.1% |
| Q1 2022 | $57,000 | +18.8% | 912 | 0.0% | 0.01% | +18.2% |
| Q4 2021 | $48,000 | -25.0% | 912 | 0.0% | 0.01% | -31.2% |
| Q3 2021 | $64,000 | +6.7% | 912 | 0.0% | 0.02% | +6.7% |
| Q2 2021 | $60,000 | -40.6% | 912 | 0.0% | 0.02% | -46.4% |
| Q1 2021 | $101,000 | -6.5% | 912 | 0.0% | 0.03% | -15.2% |
| Q4 2020 | $108,000 | +36.7% | 912 | 0.0% | 0.03% | +17.9% |
| Q3 2020 | $79,000 | -2.5% | 912 | 0.0% | 0.03% | -6.7% |
| Q2 2020 | $81,000 | -2.4% | 912 | 0.0% | 0.03% | -23.1% |
| Q1 2020 | $83,000 | -21.0% | 912 | 0.0% | 0.04% | +11.4% |
| Q4 2019 | $105,000 | -7.1% | 912 | 0.0% | 0.04% | -14.6% |
| Q3 2019 | $113,000 | +3.7% | 912 | 0.0% | 0.04% | 0.0% |
| Q2 2019 | $109,000 | – | 912 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LGT CAPITAL PARTNERS LTD. | 1,216,059 | $64,500,000 | 1.72% |
| HEARTLAND ADVISORS INC | 406,192 | $21,544,000 | 1.26% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 200,000 | $10,608,000 | 1.22% |
| Aurora Investment Counsel | 32,149 | $1,705,000 | 1.01% |
| Endurant Capital Management LP | 73,914 | $3,920,000 | 0.95% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 135,000 | $7,160,000 | 0.82% |
| ARMISTICE CAPITAL, LLC | 872,000 | $46,251,000 | 0.76% |
| Summit Creek Advisors LLC | 131,357 | $6,967,000 | 0.70% |
| Dean Capital Management | 15,309 | $812,000 | 0.70% |
| Keene & Associates, Inc. | 11,720 | $622,000 | 0.54% |